Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Giuseppe,Armentaro

第一单位： Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Catanzaro, Italy.

作者： Giuseppe,Armentaro ^[1] ; Graziella,D'Arrigo ^[2] ; Marcello,Magurno ^[1] ; Alfredo F,Toscani ^[1] ; Valentino,Condoleo ^[1] ; Sofia,Miceli ^[1] ; Velia,Cassano ^[1] ; Raffaele,Maio ^[1] ; Franco,Arturi ^[1] ; Giovanni,Tripepi ^[2] ; Giorgio,Sesti ^[3] ; Angela,Sciacqua ^[1]

作者单位： Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Catanzaro, Italy. ^[1] CNR-IFC, Istituto di Fisiologia Clinica, Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension, Reggio Calabria, Italy. ^[2] Department of Clinical and Molecular Medicine, University Rome-Sapienza, Rome, Italy. ^[3]

关键词 NT-proBNP cardiac index heart failure left ventricular ejection fraction sacubitril/valsartan

DOI 10.3389/fphar.2021.733475

PMID 34483943

发布时间 2021-09-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Frontiers in pharmacology

2021年12卷

733475页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除